Carcinostatic activity of 4-hydroxy-2-pent-en-1-al against transplantable murine tumour lines.
D000447:Aldehydes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001681:Biological Assay; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002452:Cell Count; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D006736:Horses; D066298:In Vitro Techniques; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011863:Radioimmunoassay; D012510:Sarcoma 180 / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013997:Time Factors; D014184:Transplantation, Homologous
D000447:Aldehydes